QCG
SGNT

Quadrant Capital Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Quadrant Capital Group’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-61
Closed – – 2149
2016
Q2 		$0 Buy
+61
New +$784 ﹤0.01% 2158

Quadrant Capital Group's SGNT Position: Q3 2016 in Review

Quadrant Capital Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 61 shares.

Quadrant Capital Group first reported a position in SGNT in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Quadrant Capital Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Quadrant Capital Group sold 61 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016.
  • Quadrant Capital Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2016 and held it in 1 quarter.
  • Quadrant Capital Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Quadrant Capital Group's 13F filing for Q3 2016, filed 25 Oct 2016.